Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009871 |
---|---|
Receipt number | R000011567 |
Scientific Title | Phase II study of continuation maintenance by use of TS1 and Bevacizumab after induction chemotherapy of cisplatin and TS1 pulse bevacizumab in patients with Stage IIIB / IV non-squamous and non-small cell lung cancer - Research of efficacy predictive biomarker |
Date of disclosure of the study information | 2013/01/31 |
Last modified on | 2018/09/29 16:31:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/25 17:10:08 | ||
2 | Update | 2013/08/25 10:59:14 | Email |
|
3 | Update | 2014/01/25 09:41:52 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2016/09/02 16:12:00 | Name of primary person or sponsor Organization |
|
5 | Update | 2018/05/11 15:10:54 | Recruitment status Last follow-up date |
|
6 | Update | 2018/09/29 16:30:58 | Recruitment status Last follow-up date |
|
7 | Update | 2018/09/29 16:31:49 | Name of primary person or sponsor Co-sponsor Co-sponsor |